Amgen's new leukemia drug Blincyto costs $178,000 for two courses of the treatment.» Read More
Fatalities, infections and other "hospital-acquired conditions" have plunged, and Obamacare may have helped, health officials say.
Ebola was just a wake-up call for a more serious health threat, says Barry I. Eistenstein, a doctor and senior VP at Cubist Pharmaceuticals.
Google-backed genetic testing service 23andMe is launching in the U.K., with the CEO pledging that data would not be shared with Google.
A report suggests that traffic at the Obamacare market that offers insurance to employees of small businesses is off to a less-than-inspiring start.
GSK will ax hundreds of U.S. jobs in its biggest market as the drugmaker starts implementing a major cost-saving program.
Pfizer's attempt to take over AstraZeneca through a $110 billion bid would have run aground on changes to U.S. tax laws, even if the companies had reached a deal.
An experimental Ebola vaccine made by GlaxoSmithKline caused no serious side effects, scientists reported on Wednesday.
Less than a month into Obamacare's second open-enrollment season, HHS Secretary Sylvia Mathews Burwell says "we're off to a solid start."
Pfizer’s $110 billion bid for AstraZeneca was one of the biggest business stories of 2014 – so could a new bid be one of the biggest stories in 2015?
Up to 5 million undocumented immigrants may find getting affordable health care tough despite a presidential executive order to stop deportations.
Hundreds of families from across the country have relocated or are considering moving to a state where medical marijuana is legal.
Generic drug costs have risen so much that some drugs have surpassed their equivalents in other developed countries, the New York Times reports.
The urge to stockpile Ebola protective gear in the United States has been so strong that shortages are now hitting first responders in Africa.
The head of the Health and Human Services Department wants senior staff to meet about and suggest ways to increase "transparency" at that department.
There is no escaping the fact that we’re all getting older, and investors are having to find new ways to make money from changes in the way we age.
Despite the endless controversies dogging Obamacare, the CEO of Mount Sinai believes the legislation is meeting many of its goals.
Jonathan Gruber's admission of fooling "stupid" American voters on Obamacare isn't a one-off — it's a national pastime.
A number of states have been releasing enrollment information for their Obamacare markets, but HealthCare.gov hasn't.
The Obama administration late Friday called for a slew of significant rule changes that would affect the Obamacare health-care program.
Average deductibles for the most popular Obamacare plans aren't growing much in 2015, but are still much higher than in employer-based health plans.
Get the best of CNBC in your inbox